The uremic myocardium and ischemic tolerance: A world of difference

Circulation

Volumn 125, Issue 10, 2012, Pages 1215-1216

  Dikow, Ralf ^a   Hardt, Stefan E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Editorials; Ischemic tolerance; Myocardial infarction; Renal insufficiency

Indexed keywords

HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC PRECONDITIONING; ISCHEMIC TOLERANCE; KIDNEY FUNCTION; PRIORITY JOURNAL; REVIEW; UREMIA;

ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; REPERFUSION INJURY; UREMIA;

EID: 84858442226     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.093047     Document Type: Review

References (14)

1. Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis. 2001;38:992-1000. (Pubitemid 33022177)
2. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799-805. (Pubitemid 28447453)
3. Herzog CA. Renal disease in cardiology. Nephrol Dial Transplant. 2008;23:42-46.
4. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:S16-S23.
5. Dikow R, Kihm LP, Zeier M, Kapitza J, Törnig J, Amann K, Tiefenbacher C, Ritz E. Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol. 2004;15:1530-1536. (Pubitemid 38679677)
6. Dikow R, Wasserhess C, Zimmerer K, Kihm LP, Schaier M, Schwenger V, Hardt S, Tiefenbacher C, Katus H, Zeier M, Gross ML. Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats. Basic Res Cardiol. 2009;104:571-579.
7. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998;9:1018-1022.
8. Raine A E G, Seymour A M L, Robert A F C, Radda GK, Leddingham J G G. Impairment of cardiac function and energetic in experimental renal failure. J Clin Invest. 1993;92:2934-2940. (Pubitemid 24006564)
9. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with renal disease: the Mild and Moderate Kidney Disease Study. J Am Soc Nephrol. 2005;16:1091-1098. (Pubitemid 41710320)
10. Banerjee D, Ma JZ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2:1186-1190.
11. Dikow R, Schmidt U, Kihm LP, Schaier M, Schwenger V, Gross ML, Katus HA, Zeier M, Hardt SE. Uremia aggravates left ventricular remodeling after myocardial infarction. Am J Nephrol. 2010;32:13-22.
12. Tian J, Shidyak A, Periyasamy SM, Haller S, Taleb M, El-Okdi N, Elkareh J, Gupta S, Gohara S, Fedorova OV, Cooper CJ, Xie Z, Malhotra D, Bagrov AY, Shapiro JL. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin. Hypertension. 2009;54:1313-1320.
13. Byrne CJ, McCafferty K, Kieswich J, Harwood S, Andrikopoulos P, Raftery M, Thiemermann C, Yaqoob MM. Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction. Circulation. 2012;125:1256-1265.
14. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R. Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res. 2010;87:406-423.